This announcement is a separate document:
海特生物：国投证券股份有限公司关于公司2023年度持续督导跟踪报告
Wuhan Hiteck Biological Pharma: SDIC Securities Co., Ltd.'s 2023 Continuous Supervision and Follow-up Report on the Company
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.